about
Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapySphingosine-1-Phosphate Metabolism and Its Role in the Development of Inflammatory Bowel DiseaseFormulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13.Bactericidal activity and biocompatibility of ceragenin-coated magnetic nanoparticles.Magnetic nanoparticles enhance the anticancer activity of cathelicidin LL-37 peptide against colon cancer cellsCandidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites.Bactericidal Activity of Ceragenin CSA-13 in Cell Culture and in an Animal Model of Peritoneal Infection.The Role of Cathelicidin LL-37 in Cancer Development.Core-shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas aeruginosa and Staphylococcus aureus when combined with cathelicidin LL-37 or selected ceragenins.Sporicidal activity of ceragenin CSA-13 against Bacillus subtilis.Development of antifungal therapies using nanomaterials.Anaerobic bacteria growth in the presence of cathelicidin LL-37 and selected ceragenins delivered as magnetic nanoparticles cargo.The search for new sporicidal agents for medical use: where are we?Use of magnetic nanoparticles as a drug delivery system to improve chlorhexidine antimicrobial activity.Stiffening of bacteria cells as a first manifestation of bactericidal attack.Targeting polyelectrolyte networks in purulent body fluids to modulate bactericidal properties of some antibiotics.Bactericidal and immunomodulatory properties of magnetic nanoparticles functionalized by 1,4-dihydropyridines.Ceragenin CSA-13 as free molecules and attached to magnetic nanoparticle surfaces induce caspase-dependent apoptosis in human breast cancer cells via disruption of cell oxidative balance.Plasma Gelsolin: Indicator of Inflammation and Its Potential as a Diagnostic Tool and Therapeutic TargetExpression and Function of Host Defense Peptides at Inflammation SitesToxicity of parasites and their unconventional use in medicineNanoantibiotics containing membrane-active human cathelicidin LL-37 or synthetic ceragenins attached to the surface of magnetic nanoparticles as novel and innovative therapeutic tools: current status and potential future applications
P50
Q26745710-783F3F3F-5FE8-413B-B92A-0C4CDAF8460EQ30235011-B7EF6806-7794-4FD5-8929-B361A06218C8Q33870762-90971EE0-C785-4147-AF6D-00B9EA0AFD99Q35689986-0636760E-0B7D-478E-A472-F4044006C782Q35703756-9615A4F6-ED54-4BDA-8111-C4332E3D4315Q36055572-61C5FDA6-CBC0-4A37-918A-8A8E072FFAE1Q36076086-4C8A961A-A297-46D6-870C-B535D3529171Q36465085-03CBDC6C-420D-43BC-9653-560C88CE903CQ37361845-FBAB9578-1049-42FA-80C3-EED244CFC620Q37704569-5ECDA2CA-E93F-4263-B077-87BBD6034C92Q38658275-4C740C8F-56FF-410D-AD3A-C53067E38614Q38659649-785BD766-634B-44E0-863D-D9D14636237CQ38673389-EC09C44A-A0DC-485E-B65B-78D3A0781591Q44787383-627C89D2-8735-42B1-BA70-32A9B8705D3DQ47952507-D053F53D-0E7D-4375-8A52-44F09E64F743Q49387443-8FAC7C60-BFCF-433C-A8E9-42A89E986FD6Q55195803-66A86DFA-4378-47AE-AB0C-8615342B96EBQ55255494-CE67BE94-C9CD-4D50-9C27-F051AB3A5237Q58702505-613E4484-8EBD-47D7-8A9B-E5F560D5A7B6Q92256576-940DA991-8D92-4F08-A6B5-E4DA7B11ABEDQ92305899-D17620FA-25C5-4AC4-BB0A-7092C19932E2Q92393023-F59BFA10-2842-42BA-BFDA-7A4287318163
P50
description
promovendus
@nl
researcher ORCID ID = 0000-0002-4531-7277
@en
name
Ewelina Piktel
@ast
Ewelina Piktel
@en
Ewelina Piktel
@es
Ewelina Piktel
@nl
type
label
Ewelina Piktel
@ast
Ewelina Piktel
@en
Ewelina Piktel
@es
Ewelina Piktel
@nl
prefLabel
Ewelina Piktel
@ast
Ewelina Piktel
@en
Ewelina Piktel
@es
Ewelina Piktel
@nl
P1153
56685789300
P31
P496
0000-0002-4531-7277